- ICH GCP
- EU Clinical Trials Registry
Latest Trials
EudraCT Number: 2004-002985-39 | Sponsor Protocol Number: ML18253 | Start Date: 2004-12-13 | |||||||||||
Sponsor Name: ROCHE | |||||||||||||
Full Title: A multicenter, randomized, controlled study comparing the efficacy and safety of 48 weeks of 40kD branched pegylated interferon alfa-2a (PEGASYS, Ro 25-8310) versus 96 weeks of PEGASYS, alone or in... | |||||||||||||
Medical condition: Treatment of chronic hepatitis B, HBeAg-negative | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001953-27 | Sponsor Protocol Number: 9321 | Start Date: 2004-12-13 | ||||||
Sponsor Name: University Hospitals of Leicester NHS Trust | ||||||||
Full Title: The Pharmacokinetics of Systemic Corticosteriods in Refractory Asthma | ||||||||
Medical condition: Severe, refractory asthma | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-001861-17 | Sponsor Protocol Number: | Start Date: 2004-12-12 | ||||||
Sponsor Name: NOPHO-NHL GRUPP | ||||||||
Full Title: EURO-LB-02. Treatment Protocol for Lymphoblastic Lymphoma of the European Inter-group Co-operation on Childhood Non-Hodgkin-Lymphoma (EICNHL). | ||||||||
Medical condition: Multicenter randomised trial conducted in european countries and the five nordic countries on children up to the age of 18 years newly diagnosed with T-cell and and pre -B lymphoblastic lymphoma (T... | ||||||||
|
||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||
Trial protocol: SE (Temporarily Halted) NO (Prematurely Ended) IT (Prematurely Ended) DK (Prematurely Ended) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004150-51 | Sponsor Protocol Number: A3871029 | Start Date: 2004-12-10 | |||||||||||
Sponsor Name: Pfizer Limited | |||||||||||||
Full Title: A Phase 2 multi centre, double blind, placebo controlled flexible dose study to assess the efficacy and safety of oral UK-390,957 in men with premature ejaculation. | |||||||||||||
Medical condition: Premature Ejaculation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-003798-94 | Sponsor Protocol Number: ASM981A2308 | Start Date: 2004-12-10 | ||||||
Sponsor Name: Novartis Pharma Services AG | ||||||||
Full Title: A randomized, open-label, parallel-group study to investigate blood concentrations, safety and tolerability of 2 ointment formulations of ASM981 in adult patients with atopic dermatitis treated top... | ||||||||
Medical condition: Atopic dermatitis (atopic eczema) | ||||||||
|
||||||||
Population Age: Adults | Gender: Male, Female | |||||||
Trial protocol: AT (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-002539-25 | Sponsor Protocol Number: ATOM 019 | Start Date: 2004-12-10 | |||||||||||
Sponsor Name: UNIVERSITA' DEGLI STUDI DI UDINE | |||||||||||||
Full Title: Randomized phase II trial of second-line chemotherapy with oxaliplatin and docetaxel vs. docetaxel in patients with advanced non-small cell lung cancer (NSCLC) | |||||||||||||
Medical condition: Second-line chemotherapy in advanced non small cell lung cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000499-41 | Sponsor Protocol Number: 1051/04 | Start Date: 2004-12-10 | |||||||||||
Sponsor Name: POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: mechanisms of endothelial disfunction in patients with les: role of TNF- Alpha | |||||||||||||
Medical condition: Lupus (SLE) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002980-26 | Sponsor Protocol Number: CACZ885A2102 | Start Date: 2004-12-10 | ||||||
Sponsor Name: Novartis Pharma Services AG | ||||||||
Full Title: An open-label, phase II dose titration study of ACZ885 (human anti-IL-1beta monoclonal antibody) to assess the clinical efficacy, safety, pharmacokinetics and pharmacodynamics in patients with NALP... | ||||||||
Medical condition: Muckle-Wells Syndrome: rare hereditary, autosomal dominant, systemic inflammatory disease, characterized by recurrent episodes of fever, arthralgia, myalgia, urticarial rash, and conjunctivitis. La... | ||||||||
|
||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) DE (Completed) ES (Completed) FR (Completed) Outside EU/EEA | ||||||||
Trial results: View results |
EudraCT Number: 2004-002882-19 | Sponsor Protocol Number: MCHT001 | Start Date: 2004-12-10 | ||||||
Sponsor Name: Mid Cheshire Hospitals NHS Trust | ||||||||
Full Title: A controlled trial into the benefit of topical perianal glyceryl trinitrate (GTN) as a sphincter relaxant, pre-insertion of ultrasound probe for trans rectal ultrasound (TRUS) guided biopsy of the ... | ||||||||
Medical condition: Prostate Cancer Diagnosis – Pain relief during biopsy | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002693-37 | Sponsor Protocol Number: CD-2 | Start Date: 2004-12-10 | |||||||||||
Sponsor Name: Therakos | |||||||||||||
Full Title: A MULTICENTER, OPEN-LABEL, STUDY OF EXTRACORPOREAL PHOTOIMMUNE THERAPY WITH UVADEX IN THE TREATMENT OF PATIENTS WITH MODERATELY ACTIVE CROHN’S DISEASE WHO ARE REFRACTORY OR INTOLERANT TO IMMUNOSUPP... | |||||||||||||
Medical condition: Patients with Moderately Active Crohn’s Disease Who Are Refractory or Intolerant to Immunosuppressants and/or Anti-TNF Agents | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) DE (Completed) | |||||||||||||
Trial results: (No results available) |